Skip to main content
Top
Published in: BMC Pregnancy and Childbirth 1/2003

Open Access 01-12-2003 | Technical advance

Critical pathways for the management of preeclampsia and severe preeclampsia in institutionalised health care settings

Authors: Ricardo Perez-Cuevas, William Fraser, Hortensia Reyes, Daniel Reinharz, Ashi Daftari, Cristina S Heinz, James M Roberts

Published in: BMC Pregnancy and Childbirth | Issue 1/2003

Login to get access

Abstract

Background

Preeclampsia is a complex disease in which several providers should interact continuously and in a coordinated manner to provide proper health care. However, standardizing criteria to treat patients with preeclampsia is problematical and severe flaws have been observed in the management of the disease. This paper describes a set of critical pathways (CPs) designed to provide uniform criteria for clinical decision-making at different levels of care of pregnant patients with preeclampsia or severe preeclampsia.

Methods

Clinicians and researchers from different countries participated in the construction of the CPs. The CPs were developed using the following steps: a) Definition of the conceptual framework; b) Identification of potential users: primary care physicians and maternal and child health nurses in ambulatory settings; ob/gyn and intensive care physicians in secondary and tertiary care levels. c) Structural development.

Results

The CPs address the following care processes: 1. Screening for preeclampsia, risk assessment and classification according to the level of risk. 2. Management of preeclampsia at primary care clinics. 3. Evaluation and management of preeclampsia at secondary and tertiary care hospitals: 4. Criteria for clinical decision-making between conservative management and expedited delivery of patients with severe preeclampsia.

Conclusion

Since preeclampsia continues to be one of the primary causes of maternal deaths and morbidity worldwide, the expected impact of these CPs is the contribution to improving health care quality in both developed and developing countries. The CPs are designed to be applied in a complex health care system, where different physicians and health providers at different levels of care should interact continuously and in a coordinated manner to provide care to all preeclamptic women. Although the CPs were developed using evidence-based criteria, they could require careful evaluation and remodelling according to each system's demands. Additionally, the CPs need to be tested in large-scale, multi-level studies in order to thoroughly examine and evaluate their efficacy and effectiveness.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sox H, Blatt M, Higgins M, Marton K: Medical Decision Making. Butterworth-Heinemann, Newton MA. 1988 Sox H, Blatt M, Higgins M, Marton K: Medical Decision Making. Butterworth-Heinemann, Newton MA. 1988
2.
go back to reference Belizan JM, Villar J, Gonzalez L, Campodonico L, Bergel E: Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med. 1991, 325: 1399-405.CrossRefPubMed Belizan JM, Villar J, Gonzalez L, Campodonico L, Bergel E: Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med. 1991, 325: 1399-405.CrossRefPubMed
3.
go back to reference Repke JT, Robinson JN: The prevention and management of preeclampsia and eclampsia. Int J Gynecol & Obstet. 1998, 61: 1-9. 10.1016/S0020-7292(98)00082-4.CrossRef Repke JT, Robinson JN: The prevention and management of preeclampsia and eclampsia. Int J Gynecol & Obstet. 1998, 61: 1-9. 10.1016/S0020-7292(98)00082-4.CrossRef
4.
go back to reference Witlin A, Sibai B: Hypertension in pregnancy: Current concepts of preeclampsia. Annu Rev Med. 1997, 48: 115-127. 10.1146/annurev.med.48.1.115.CrossRefPubMed Witlin A, Sibai B: Hypertension in pregnancy: Current concepts of preeclampsia. Annu Rev Med. 1997, 48: 115-127. 10.1146/annurev.med.48.1.115.CrossRefPubMed
5.
go back to reference Roberts J, Section V Editor: The Etiology of Preeclampsia. In Chesley's Hypertensive Disorders in Pregnancy Stamford, CT, Appleton & Lange. Edited by: Lindheimer, Roberts and Cunningham. 1999, 377-516. Second Roberts J, Section V Editor: The Etiology of Preeclampsia. In Chesley's Hypertensive Disorders in Pregnancy Stamford, CT, Appleton & Lange. Edited by: Lindheimer, Roberts and Cunningham. 1999, 377-516. Second
6.
go back to reference Caritis S, Sibai B, Hauth J, Lindheimer M, VanDorsten P, et al: Predictors of preeclampsia in women at high risk. Am J Obstet Gynecol. 1998, 179: 946-951.CrossRefPubMed Caritis S, Sibai B, Hauth J, Lindheimer M, VanDorsten P, et al: Predictors of preeclampsia in women at high risk. Am J Obstet Gynecol. 1998, 179: 946-951.CrossRefPubMed
7.
go back to reference Khedun SM, Moodley J, Naicker T, Maharaj B: Drug management of hypertensive disorders of pregnancy. Pharmacol Ther. 1997, 74: 221-58. 10.1016/S0163-7258(97)82005-0.PubMed Khedun SM, Moodley J, Naicker T, Maharaj B: Drug management of hypertensive disorders of pregnancy. Pharmacol Ther. 1997, 74: 221-58. 10.1016/S0163-7258(97)82005-0.PubMed
8.
go back to reference Lewis R, Sibai B: Recent advances in the management of preeclampsia. Matern Foetal Med. 1997, 6: 6-15. 10.1002/(SICI)1520-6661(199701/02)6:1<6::AID-MFM2>3.0.CO;2-T. Lewis R, Sibai B: Recent advances in the management of preeclampsia. Matern Foetal Med. 1997, 6: 6-15. 10.1002/(SICI)1520-6661(199701/02)6:1<6::AID-MFM2>3.0.CO;2-T.
9.
go back to reference Walker JJ: Care of the patient with severe pregnancy induced hypertension. Eur J Obstet & Gynecol and Rep Biology. 1996, 65: 127-135. 10.1016/0028-2243(95)02318-M.CrossRef Walker JJ: Care of the patient with severe pregnancy induced hypertension. Eur J Obstet & Gynecol and Rep Biology. 1996, 65: 127-135. 10.1016/0028-2243(95)02318-M.CrossRef
10.
go back to reference Helewa M, Burrows R, Smith J, Williams k, Brain P, Rabkin S: Report on the Canadian Hypertension Society Consensus Conference:1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ. 1997, 157: 715-725.PubMedPubMedCentral Helewa M, Burrows R, Smith J, Williams k, Brain P, Rabkin S: Report on the Canadian Hypertension Society Consensus Conference:1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ. 1997, 157: 715-725.PubMedPubMedCentral
11.
go back to reference Moutquin JM, Garner PR, Burrows RF, Rey E, Helewa ME, Lange IR, Rabkin SW: Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. CMAJ. 1997, 157 (7): 907-19.PubMedPubMedCentral Moutquin JM, Garner PR, Burrows RF, Rey E, Helewa ME, Lange IR, Rabkin SW: Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. CMAJ. 1997, 157 (7): 907-19.PubMedPubMedCentral
12.
go back to reference Rey E, LeLorier J, Burgess E, Lange I, Leduc L: Report of the Canadian Hypertension Society Consensus Conference:3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ. 1997, 157 (9): 1245-54.PubMedPubMedCentral Rey E, LeLorier J, Burgess E, Lange I, Leduc L: Report of the Canadian Hypertension Society Consensus Conference:3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ. 1997, 157 (9): 1245-54.PubMedPubMedCentral
13.
go back to reference Pearson SD, Goulart-Fisher D, Lee TH: Critical pathways as a strategy for improving care: problems and potential. Ann Intern Med. 1995, 123 (12): 941-948.CrossRefPubMed Pearson SD, Goulart-Fisher D, Lee TH: Critical pathways as a strategy for improving care: problems and potential. Ann Intern Med. 1995, 123 (12): 941-948.CrossRefPubMed
15.
go back to reference Evidence-Based Care Resource Group: Evidence-Based care: 2. Setting Guidelines: How should we manage this problem?. CMAJ. 1994, 150 (9): 1417-1423. Evidence-Based Care Resource Group: Evidence-Based care: 2. Setting Guidelines: How should we manage this problem?. CMAJ. 1994, 150 (9): 1417-1423.
16.
go back to reference Brassard M, Ritter D: The Memory Jogger II. GOAL/QPC Methuen MA. 1994 Brassard M, Ritter D: The Memory Jogger II. GOAL/QPC Methuen MA. 1994
17.
go back to reference Rymer MM, Summers D, Soper P: Development of Clinical Pathways for Stroke Management: An Example from Saint Luke's Hospital, Kansas City. Clin Geriatr Med. 1999, 15 (4): 741-764.PubMed Rymer MM, Summers D, Soper P: Development of Clinical Pathways for Stroke Management: An Example from Saint Luke's Hospital, Kansas City. Clin Geriatr Med. 1999, 15 (4): 741-764.PubMed
18.
go back to reference Velasco V, Navarrete H, Cardona J, Madrazo M: Mortalidad Materna por Preeclampsia en el Instituto Mexicano del Seguro Social. Rev Med IMSS. 1997, 35 (6): 439-444. Velasco V, Navarrete H, Cardona J, Madrazo M: Mortalidad Materna por Preeclampsia en el Instituto Mexicano del Seguro Social. Rev Med IMSS. 1997, 35 (6): 439-444.
20.
go back to reference Velasco V, Navarrete H, Cardona J, Madrazo M: Mortalidad Materna en el Instituto Mexicano del Seguro Social 1987–1996. Rev Med IMSS (Mex). 1997, 35 (5): 377-383. Velasco V, Navarrete H, Cardona J, Madrazo M: Mortalidad Materna en el Instituto Mexicano del Seguro Social 1987–1996. Rev Med IMSS (Mex). 1997, 35 (5): 377-383.
21.
go back to reference Coordinación de Salud Reproductiva y Materno Infantil: Norma Técnico-Medica para la prevención y manejo de la preeclampsia eclampsia. Instituto Mexicano del Seguro Social, Mexico. 1995 Coordinación de Salud Reproductiva y Materno Infantil: Norma Técnico-Medica para la prevención y manejo de la preeclampsia eclampsia. Instituto Mexicano del Seguro Social, Mexico. 1995
22.
go back to reference Silagy CA, Weller DP, Lapsley H, Middleton P, Shelby-James T, Fazekas B: The effectiveness of local adaptation of nationally produced clinical practice guidelines. Fam Prac. 2002, 19 (3): 223-230. 10.1093/fampra/19.3.223.CrossRef Silagy CA, Weller DP, Lapsley H, Middleton P, Shelby-James T, Fazekas B: The effectiveness of local adaptation of nationally produced clinical practice guidelines. Fam Prac. 2002, 19 (3): 223-230. 10.1093/fampra/19.3.223.CrossRef
23.
go back to reference Langley C, Faulkner A, Watkins Ch, Gray S, Harvey I: Use of guidelines in primary care. Practitioners perspectives. 1998, 15: 105-111. 10.1093/fampra/15.2.105. Langley C, Faulkner A, Watkins Ch, Gray S, Harvey I: Use of guidelines in primary care. Practitioners perspectives. 1998, 15: 105-111. 10.1093/fampra/15.2.105.
24.
go back to reference Perez-Cuevas R, Reyes-Morales H, Trejo y, Perez JA, Oviedo-Mota MA, Flores-Hernández S: Las guías clínicas: Instrumentos útiles para mejorar el desempeño de los servicios de salud. In Guías de Práctica Clínica para Medicina Familiar. Edited by: Reyes-Morales H, Trejo y Perez JA, Oviedo-Mota MA, Perez-Cuevas R, surFlores-Hernández. 2004, Mexico: Instituto Mexicano del Seguro Social, : - Perez-Cuevas R, Reyes-Morales H, Trejo y, Perez JA, Oviedo-Mota MA, Flores-Hernández S: Las guías clínicas: Instrumentos útiles para mejorar el desempeño de los servicios de salud. In Guías de Práctica Clínica para Medicina Familiar. Edited by: Reyes-Morales H, Trejo y Perez JA, Oviedo-Mota MA, Perez-Cuevas R, surFlores-Hernández. 2004, Mexico: Instituto Mexicano del Seguro Social, : -
25.
go back to reference Cincotta RB, Brennecke SP: Family history of preeclampsia as a predictor for preeclampsia in primigravidas. Int J Gynecol & Obstet. 1998, 60: 23-27. 10.1016/S0020-7292(97)00241-5.CrossRef Cincotta RB, Brennecke SP: Family history of preeclampsia as a predictor for preeclampsia in primigravidas. Int J Gynecol & Obstet. 1998, 60: 23-27. 10.1016/S0020-7292(97)00241-5.CrossRef
26.
go back to reference Stone J, Lockwood Ch, Berkowitz G, Alvarez M, Lapinski R, Berkowitz R: Risk factors for severe preeclampsia. Obstet Gynecol. 1994, 83: 357-361.PubMed Stone J, Lockwood Ch, Berkowitz G, Alvarez M, Lapinski R, Berkowitz R: Risk factors for severe preeclampsia. Obstet Gynecol. 1994, 83: 357-361.PubMed
27.
go back to reference Roberts JM, Redman CWG: Preeclampsia: more than pregnancy-induced hypertension. Lancet. 1993, 341: 1447-1451. 10.1016/0140-6736(93)90889-O.CrossRefPubMed Roberts JM, Redman CWG: Preeclampsia: more than pregnancy-induced hypertension. Lancet. 1993, 341: 1447-1451. 10.1016/0140-6736(93)90889-O.CrossRefPubMed
28.
go back to reference Chien PF, Khan KS, Arnott N: Magnesium sulphate in the treatment of eclampsia and preeclampsia: an overview of the evidence from randomised trials. Br J Obstet Gynaecol. 1996, 103 (11): 1085-1091.CrossRefPubMed Chien PF, Khan KS, Arnott N: Magnesium sulphate in the treatment of eclampsia and preeclampsia: an overview of the evidence from randomised trials. Br J Obstet Gynaecol. 1996, 103 (11): 1085-1091.CrossRefPubMed
29.
go back to reference Coetzee EJ, Dommisse J, Anthony J: A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe preeclampsia. Br J Obstet Gynaecol. 1998, 105: 300-303.CrossRefPubMed Coetzee EJ, Dommisse J, Anthony J: A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe preeclampsia. Br J Obstet Gynaecol. 1998, 105: 300-303.CrossRefPubMed
30.
go back to reference Sibai BM, Mercer B, Schiff E, Friedman S: Aggressive versus expectant management of severe preeclampsia at 28–32 weeks' gestation: a randomised controlled trial. Am J Obstet Gynecol. 1994, 171: 818-822.CrossRefPubMed Sibai BM, Mercer B, Schiff E, Friedman S: Aggressive versus expectant management of severe preeclampsia at 28–32 weeks' gestation: a randomised controlled trial. Am J Obstet Gynecol. 1994, 171: 818-822.CrossRefPubMed
31.
go back to reference Visser W, Pampus M, Treffers P, Wallenburg H: Perinatal results of homodynamic and conservative temporising treatment in severe preeclampsia. J Obstet & Gynecol and Reproductive Biology. 1994, 53: 175-181.CrossRef Visser W, Pampus M, Treffers P, Wallenburg H: Perinatal results of homodynamic and conservative temporising treatment in severe preeclampsia. J Obstet & Gynecol and Reproductive Biology. 1994, 53: 175-181.CrossRef
32.
go back to reference Schiff E, Friedman S, Sibai B: Conservative management of severe preeclampsia remote from term. Obstet Gynecol. 1994, 84: 626-30.PubMed Schiff E, Friedman S, Sibai B: Conservative management of severe preeclampsia remote from term. Obstet Gynecol. 1994, 84: 626-30.PubMed
33.
go back to reference Friedman SA, Schiff E, Lubarsky SL, Sibai SM: Expectant management of severe preeclampsia remote from term. Clin Obstet Gynecol. 1999, 42 (3): 470-488. 10.1097/00003081-199909000-00005.CrossRefPubMed Friedman SA, Schiff E, Lubarsky SL, Sibai SM: Expectant management of severe preeclampsia remote from term. Clin Obstet Gynecol. 1999, 42 (3): 470-488. 10.1097/00003081-199909000-00005.CrossRefPubMed
34.
go back to reference Ellis BW, Johnson S: The care pathway: a tool to enhance clinical governance. Clin Perform Qual Health Care. 1999, 7 (3): 134-144.CrossRefPubMed Ellis BW, Johnson S: The care pathway: a tool to enhance clinical governance. Clin Perform Qual Health Care. 1999, 7 (3): 134-144.CrossRefPubMed
35.
go back to reference Carnet WG: Clinical Practice Guidelines: a tool to improve care. Qual Manag Health Care. 1999, 8 (1): 13-21.CrossRef Carnet WG: Clinical Practice Guidelines: a tool to improve care. Qual Manag Health Care. 1999, 8 (1): 13-21.CrossRef
36.
go back to reference Ghosh K, Downs LS, Padilla LA, Murray KP, Twiggs LB, Letourneau CM, Carson LF: The implementation of critical pathways in gynaecologic oncology in a managed care setting: a cost analysis. Gynecol Oncol. 2001, 83 (2): 378-82. 10.1006/gyno.2001.6428.CrossRefPubMed Ghosh K, Downs LS, Padilla LA, Murray KP, Twiggs LB, Letourneau CM, Carson LF: The implementation of critical pathways in gynaecologic oncology in a managed care setting: a cost analysis. Gynecol Oncol. 2001, 83 (2): 378-82. 10.1006/gyno.2001.6428.CrossRefPubMed
37.
go back to reference Wazeka A, Valacer DJ, Cooper M, Caplan DW, DiMaio M: Impact of a pediatric asthma clinical pathway on hospital cost and length of stay. Pediatr Pulmonol. 2001, 32 (3): 211-6. 10.1002/ppul.1110.CrossRefPubMed Wazeka A, Valacer DJ, Cooper M, Caplan DW, DiMaio M: Impact of a pediatric asthma clinical pathway on hospital cost and length of stay. Pediatr Pulmonol. 2001, 32 (3): 211-6. 10.1002/ppul.1110.CrossRefPubMed
38.
go back to reference Simon NV, Heaps KP, Chodroff CH: Improving the processes of care and outcomes in obstetrics/gynecology. Jt Comm J Qual Improv. 1997, 23 (9): 485-97.PubMed Simon NV, Heaps KP, Chodroff CH: Improving the processes of care and outcomes in obstetrics/gynecology. Jt Comm J Qual Improv. 1997, 23 (9): 485-97.PubMed
39.
go back to reference Choo J: Critical success factors in implementing clinical pathways/case management. Ann Acad Med Singapore. 2001, 30 (4 Suppl): 17-21.PubMed Choo J: Critical success factors in implementing clinical pathways/case management. Ann Acad Med Singapore. 2001, 30 (4 Suppl): 17-21.PubMed
40.
go back to reference Anonymous: Involve nurses and patients to change physician behavior. Clin Resour manag. 2001, 2 (9): 135-9. Anonymous: Involve nurses and patients to change physician behavior. Clin Resour manag. 2001, 2 (9): 135-9.
Metadata
Title
Critical pathways for the management of preeclampsia and severe preeclampsia in institutionalised health care settings
Authors
Ricardo Perez-Cuevas
William Fraser
Hortensia Reyes
Daniel Reinharz
Ashi Daftari
Cristina S Heinz
James M Roberts
Publication date
01-12-2003
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2003
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/1471-2393-3-6

Other articles of this Issue 1/2003

BMC Pregnancy and Childbirth 1/2003 Go to the issue